hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06326983, orgStudyIdInfo id: IRB-P00047028, briefTitle: Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2026-04-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Boston Children's Hospital, class: OTHER, descriptionModule briefSummary: This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic plan (dexmedetomidine, ketorolac and acetaminophen) for perioperative analgesia and recovery time in patients undergoing tonsillectomies and tonsillotomies at Boston Children's Hospital Waltham. Secondary measures include rescue opioids administered in post-anesthesia care unit (PACU), re-operation secondary to bleeding, emergence delirium, post-operative nausea and vomiting, intraoperative hemodynamics, intraoperative vasopressor administration, and length of procedure., conditionsModule conditions: Tonsillitis, conditions: Post-operative Nausea and Vomiting (PONV), conditions: Emergence Delirium, conditions: Opioid Analgesic Adverse Reaction, conditions: Anesthesia, conditions: Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 58, type: ESTIMATED, armsInterventionsModule interventions name: Dexmedetomidine, interventions name: Acetaminophen, interventions name: Ketorolac, interventions name: Morphine, outcomesModule primaryOutcomes measure: Median Pain Scores in the Post-Anesthesia Care Unit, primaryOutcomes measure: Post-operative pain at 12-24 hours, primaryOutcomes measure: Post Operative Anesthesia Unit Length of Stay (hours), secondaryOutcomes measure: Opioid rescue medication administration, secondaryOutcomes measure: Emergence Delirium, secondaryOutcomes measure: Post-operative nausea and vomiting, secondaryOutcomes measure: Procedure length (minutes), secondaryOutcomes measure: Intraoperative Blood pressure (mmHg), secondaryOutcomes measure: Intraoperative Heart rate (beats per second), secondaryOutcomes measure: Vasopressor administration, eligibilityModule sex: ALL, minimumAge: 3 Years, maximumAge: 17 Years, stdAges: CHILD, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06326970, orgStudyIdInfo id: HenanICE202401, briefTitle: SPECT Fibroblast Activation Protein Imaging in Patients With Cardiac Disease, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-03, completionDateStruct date: 2025-03, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: Henan Institute of Cardiovascular Epidemiology, class: OTHER, descriptionModule briefSummary: This observational study aims to learn about the preliminary exploration of 99mTc-FAPI imaging in heart diseases and its potential application.Participant involves patients with myocarditis, pulmonary hypertension, arrhythmia, myocardial infarction, dilated cardiomyopathy, and cardiac tumors, health conditions may also studied as control.The main questions it aims to answer are 1, radionuclide 99mTc labeled fibroblast-activated protein inhibitors (99mTc-FAPI) imaging in the use of cardiac diseases and its limitations. 2, the performance in subjects with different control of hypertension to evaluate myocardial injury and fibrosis for providing a molecular biological basis for the study of diseases and mechanisms.Participants will undergo 99mTc-FAPI imaging by Single-photon emission computed tomography (SPECT) and record their cardiac disease characterization and treatment., conditionsModule conditions: Myocardial Fibrosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: 99mTc-FAPI SPECT imaging, outcomesModule primaryOutcomes measure: positive uptake, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06326944, orgStudyIdInfo id: MS-527-2023, briefTitle: Fascia Transversalis Versus Transversus Abdominis Plane Block for Children Undergoing Inguinal Hernia Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-18, primaryCompletionDateStruct date: 2024-04, completionDateStruct date: 2024-05, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: Kasr El Aini Hospital, class: OTHER, descriptionModule briefSummary: Fascia transversalis block in pediatrics undergoing inguinal surgical repair may be simple technique and may give longer effect in reduction of post-operative pain in comparison to transversus abdominis plane block., conditionsModule conditions: Fascia Transversalis Plane Block, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Ultrasound- guided Fascia Transversalis plane block, interventions name: Ultrasound-guided Transversus abdominus plane block, interventions name: Fentanyl, interventions name: Pethidine, interventions name: Acetaminophen, outcomesModule primaryOutcomes measure: Time to First need of analgesia, secondaryOutcomes measure: Total Pethidine Consumption, secondaryOutcomes measure: Postoperative pain assessment FLACC, eligibilityModule sex: ALL, minimumAge: 1 Year, maximumAge: 6 Years, stdAges: CHILD, contactsLocationsModule locations facility: Cairo University Hospitals, status: RECRUITING, city: Giza, zip: 11562, country: Egypt, contacts name: Maher a Fawzy, MD, role: CONTACT, phone: 01201730249, email: kasralainirec@kasralainy.edu.eg, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06326931, orgStudyIdInfo id: JE001, briefTitle: Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-06-24, primaryCompletionDateStruct date: 2023-06-22, completionDateStruct date: 2023-06-22, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: Jacksoneye, class: OTHER, descriptionModule briefSummary: This study aimed to assess the treatment outcome differences between a single, in-office bilateral treatment with the thermal pulsation system and twice-daily, 10-minute applications of the warm compress mask at home for 8 weeks., conditionsModule conditions: Meibomian Gland Dysfunction, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Prospective, randomized, controlled clinical trial, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: The clinician evaluating MGS score was masked to subject treatment assignment, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 68, type: ACTUAL, armsInterventionsModule interventions name: thermal pulsation, interventions name: warm compress, outcomesModule primaryOutcomes measure: Change in MGS score for the worse eye, secondaryOutcomes measure: Change in MGS score for the worse eye, secondaryOutcomes measure: Change in OSDI score, secondaryOutcomes measure: Change in OSDI score, secondaryOutcomes measure: Incidence of adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Jacksoneye, city: Lake Villa, state: Illinois, zip: 60046, country: United States, geoPoint lat: 42.41697, lon: -88.07397, hasResults: False
protocolSection identificationModule nctId: NCT06326918, orgStudyIdInfo id: RP026, briefTitle: Duodenal Microbiota in Functional Dyspepsia, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-12, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: King Chulalongkorn Memorial Hospital, class: OTHER, descriptionModule briefSummary: The goal of this observational study is to assess the type of duodenal microbiota and duodenal microbiome in in FD patients compared to control group. The main questions it aims to answer are:* What are the differences in the type of duodenal microbiota and is there a difference in duodenal microbiome diversity between patients diagnosed with functional dyspepsia (FD) and the control group?* Are there any significant variations in the composition and diversity of gut microbiota between patients with FD and the control group, considering the method of sample collection (duodenal brushing vs. duodenal biopsy)?, conditionsModule conditions: Functional Dyspepsia, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Duodenal mucosal brushing, interventions name: Duodenal mucosal biopsy, outcomesModule primaryOutcomes measure: Specific microbial genus using mucosal brushing, primaryOutcomes measure: Microbiome diversity using mucosal brushing, secondaryOutcomes measure: Specific microbial genus using mucosal biopsy, secondaryOutcomes measure: Microbiome diversity using mucosal biopsy, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: King Chulalongkorn Memorial Hospital, status: RECRUITING, city: Bangkok, zip: 10330, country: Thailand, contacts name: Rapat Pittayanon, MD, role: CONTACT, phone: +66813132112, email: rapat125@gmail.com, contacts name: Chatpol Samuthpongtorn, MD, role: CONTACT, phone: +66813462108, email: csamuthpongtorn@gmail.com, geoPoint lat: 13.75398, lon: 100.50144, hasResults: False
protocolSection identificationModule nctId: NCT06326892, orgStudyIdInfo id: CHR1-101-2024, briefTitle: Natural Orifice Specimen Extraction in Low Rectal Cancer Surgery, acronym: NOSES, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-07-31, primaryCompletionDateStruct date: 2024-04-30, completionDateStruct date: 2024-10-15, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Istituto Clinico Humanitas, class: OTHER, descriptionModule briefSummary: This study aims to compare the postoperative outcomes of low rectal cancer patients who underwent surgery with Natural Orifice Specimen Extraction (NOSE) versus traditional Pfannenstiel extraction., conditionsModule conditions: Rectal Cancer, conditions: Surgery, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 350, type: ESTIMATED, armsInterventionsModule interventions name: Natural Orifice Specimen Extraction (NOSE), interventions name: Traditional specimen extraction, outcomesModule primaryOutcomes measure: Surgical Site Infections (SSI), secondaryOutcomes measure: Opioid rescue, secondaryOutcomes measure: Postoperative pain, secondaryOutcomes measure: Postoperative ileus, secondaryOutcomes measure: Incisional hernia, secondaryOutcomes measure: Overall postoperative complications, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: IRCCS Humanitas Research Hospital, status: RECRUITING, city: Rozzano, state: MI, zip: 20089, country: Italy, contacts name: Annalisa Maroli, PhD, role: CONTACT, phone: 02 8224 7776, phoneExt: 0039, email: colorapp@humanitas.it, contacts name: Stefano De Zanet, MS, role: CONTACT, phone: 02 8224 4623, phoneExt: 0039, email: colorapp@humanitas.it, geoPoint lat: 45.38193, lon: 9.1559, hasResults: False
protocolSection identificationModule nctId: NCT06326879, orgStudyIdInfo id: 3527, briefTitle: A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients, acronym: EOrOS, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-30, primaryCompletionDateStruct date: 2026-12-31, completionDateStruct date: 2027-10-30, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Istituto Clinico Humanitas, class: OTHER, descriptionModule briefSummary: This study aims to investigate the clinical, socioeconomic, behavioral, genetic, and molecular factors characterizing Early Onset Colorectal Cancer (EOCRC) patients compared with Late Onset Colorectal Cancer (LOCRC) patients, conditionsModule conditions: Colorectal Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 340, type: ESTIMATED, armsInterventionsModule interventions name: No intervention, outcomesModule primaryOutcomes measure: Incidence rate ratio of colorectal cancer recurrence, secondaryOutcomes measure: Correlation between lifestyle and incidence rate of colorectal cancer recurrence, secondaryOutcomes measure: Correlation between genetic profile and incidence rate of colorectal cancer recurrence, secondaryOutcomes measure: Correlation between molecular profile and incidence rate of colorectal cancer recurrence, secondaryOutcomes measure: Correlation between socioeconomic characteristics and incidence rate of colorectal cancer recurrence, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: IRCCS Humanitas Research Hospital, status: RECRUITING, city: Rozzano, state: MI, zip: 20089, country: Italy, contacts name: Annalisa Maroli, PhD, role: CONTACT, phone: 02 8224 7776, phoneExt: 0039, email: colorapp@humanitas.it, contacts name: Stefano De Zanet, MS, role: CONTACT, phone: 02 8224 4623, phoneExt: 0039, email: colorapp@humanitas.it, geoPoint lat: 45.38193, lon: 9.1559, hasResults: False
protocolSection identificationModule nctId: NCT06326866, orgStudyIdInfo id: E-74555795-050.04-941208, briefTitle: Otoacoustic Emissions in Different Blood Types, statusModule overallStatus: COMPLETED, startDateStruct date: 2024-02-07, primaryCompletionDateStruct date: 2024-03-12, completionDateStruct date: 2024-03-18, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: Istanbul University - Cerrahpasa (IUC), class: OTHER, descriptionModule briefSummary: The objective of this study is to examine whether ABO and Rhesus (Rh) blood group systems have an association with distortion product otoacoustic emission (DPOAE) and transient otoacoustic emission (TEOAE) amplitudes with the hypothesis of blood groups may affect hearing thresholds., conditionsModule conditions: Hearing Loss, Cochlear, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 70, type: ACTUAL, armsInterventionsModule interventions name: Otoacoustic emissions (non-invasive), outcomesModule primaryOutcomes measure: Signal to noise ratios, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 26 Years, stdAges: ADULT, contactsLocationsModule locations facility: Eyyup KARA, city: İstanbul, zip: 34107, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06326853, orgStudyIdInfo id: Adipofisi, briefTitle: Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-03, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: IRCCS San Raffaele, class: OTHER, descriptionModule briefSummary: The goal of this observational study is to evaluate, retrospectively and prospectively, the effect of different hormonal and neuropeptide dysfunctions on the body composition of patients suffering from hypothalamic-pituitary pathologies, and to evaluate the potential beneficial effect of surgical and medical treatments with agonists and antagonists of hypothalamic neuropeptides, currently available, on the development and treatment of adiposity and negative cross-talk between adiposity and muscle/bone tissue, conditionsModule conditions: Endocrine Disorders, conditions: Adiposity, conditions: Pituitary Adenoma, conditions: Cushing Syndrome, conditions: Acromegaly, conditions: Hypopituitarism, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 200, type: ESTIMATED, outcomesModule primaryOutcomes measure: Rate of patients with BMI greater than 30 with hypothalamic-pituitary pathologies, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06326840, orgStudyIdInfo id: 98107, briefTitle: Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment, statusModule overallStatus: COMPLETED, startDateStruct date: 2010-05-31, primaryCompletionDateStruct date: 2011-06-10, completionDateStruct date: 2011-06-10, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: Taipei Medical University Hospital, class: OTHER, collaborators name: Taipei Medical University, descriptionModule briefSummary: The goal of this clinical trial is to explore the potential of metformin in managing olanzapine-induced metabolic disturbance and hyperprolactinemia in patients with schizophrenia. The main questions it aims to answer are:1. The effect of metformin on olanzapine-induced metabolic disturbance2. The effect of metformin on olanzapine-induced hyperprolactinemiaParticipants will receive metformin 1500 mg/day for 8 weeks and assessments every 2 weeks., conditionsModule conditions: Metabolic Disturbance, conditions: Hyperprolactinemia, conditions: Schizophrenia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 42, type: ACTUAL, armsInterventionsModule interventions name: Metformin, outcomesModule primaryOutcomes measure: Glucose level, primaryOutcomes measure: prolactin level, primaryOutcomes measure: Insulin level, primaryOutcomes measure: low-density lipoprotein cholesterol (LDL-C) level, primaryOutcomes measure: high-density lipoprotein cholesterol (HDL-C) level, primaryOutcomes measure: cholesterol level, primaryOutcomes measure: triglycerides level, primaryOutcomes measure: leptin level, secondaryOutcomes measure: Clinical Global Impression scale, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Taipei Medical University-Wan Fang Hospital, city: Taipei, zip: 116, country: Taiwan, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False
protocolSection identificationModule nctId: NCT06326827, orgStudyIdInfo id: P231127IBSORTHO, briefTitle: In'Oss™ (MBCP® Putty) Ortho, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2026-05, completionDateStruct date: 2026-08, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-29, sponsorCollaboratorsModule leadSponsor name: Advanced Medical Solutions Ltd., class: INDUSTRY, descriptionModule briefSummary: Study of the osteoconductive potential of the injectable bone substitute In'Oss™ (MBCP® Putty) in the filling of orthopaedic bone defects to collect Post-Market Clinical Follow-up (PMCF) data for the CE-marked In'Oss™ (MBCP® Putty) device in the orthopaedic trauma surgery, conditionsModule conditions: Orthopedic Disorder, conditions: Trauma Injury, conditions: Extremity Injury, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: In'Oss™ (MBCP® Putty), outcomesModule primaryOutcomes measure: Successful bone defect reconstruction in the extremities, secondaryOutcomes measure: Evaluation of functional mobility restoration in the extremities with PRO measures, secondaryOutcomes measure: Evaluation of patient's pain intensity with VAS pain scale, secondaryOutcomes measure: Evaluation of safety of In'Oss, secondaryOutcomes measure: Evaluation of device usability, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 85 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06326801, orgStudyIdInfo id: REC/014220 Muhammad Iqbal, briefTitle: Resistive Diaphragmatic Breathing Exercise With Pursed Lips Breathing Exercise in Sub-acute Stroke Patients, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-09-01, primaryCompletionDateStruct date: 2024-01-15, completionDateStruct date: 2024-01-18, studyFirstPostDateStruct date: 2024-03-22, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: To determine whether resistive diaphragmatic breathing exercise with pursed lips breathing exercise improve pulmonary function in sub-acute ischemic stroke, To determine whether resistive diaphragmatic breathing exercise with pursed lips breathing exercise improve Trunk Control in sub-acute ischemic stroke, To determine whether resistive diaphragmatic breathing exercise with pursed lips breathing exercise improve Functional Capacity in sub-acute ischemic stroke, conditionsModule conditions: Stroke, Ischemic, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 27, type: ACTUAL, armsInterventionsModule interventions name: Resistive Diaphragmatic breathing exercise, interventions name: Diaphragmatic breathing exercise, interventions name: Conventional stroke physiotherapy, outcomesModule primaryOutcomes measure: pulmonary function, primaryOutcomes measure: Trunk Control, primaryOutcomes measure: Functional Capacity, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Northwest General Hospital, Peshawar;, city: Peshawar, state: Punjab, zip: 44000, country: Pakistan, geoPoint lat: 34.008, lon: 71.57849, hasResults: False